Penserra Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $215K | Sell |
597
-188
| -24% | -$64.4K | ﹤0.01% | 692 |
|
|
2026
Q1 | $275K | Buy |
785
+165
| +27% | +$58.8K | ﹤0.01% | 609 |
|
|
2025
Q4 | $202K | Sell |
620
-131
| -17% | -$41.6K | ﹤0.01% | 674 |
|
|
2025
Q3 | $211K | Buy |
751
+16
| +2% | +$4.64K | ﹤0.01% | 700 |
|
|
2025
Q2 | $204K | Sell |
735
-1,108
| -60% | -$314K | ﹤0.01% | 651 |
|
|
2025
Q1 | $573K | Sell |
1,843
-311
| -14% | -$91.8K | 0.01% | 572 |
|
|
2024
Q4 | $559K | Buy |
2,154
+1,388
| +181% | +$412K | 0.01% | 544 |
|
|
2024
Q3 | $246K | Sell |
766
-425,146
| -100% | -$139M | 0.01% | 674 |
|
|
2024
Q2 | $133M | Buy |
425,912
+150,471
| +55% | +$44.2M | 1.68% | 12 |
|
|
2024
Q1 | $78.3M | Buy |
275,441
+272,963
| +11,015% | +$79.9M | 0.98% | 27 |
|
|
2023
Q4 | $712K | Sell |
2,478
-518
| -17% | -$141K | 0.01% | 436 |
|
|
2023
Q3 | $805K | Sell |
2,996
-466
| -13% | -$116K | 0.02% | 399 |
|
|
2023
Q2 | $767K | Buy |
3,462
+3,434
| +12,264% | +$797K | 0.02% | 415 |
|
|
2023
Q1 | $6K | Sell |
28
-298,458
| -100% | -$73.3M | ﹤0.01% | 944 |
|
|
2022
Q4 | $78.4M | Buy |
+298,486
| New | +$80M | 1.72% | 17 |
|
|
2022
Q2 | – | Sell |
-108
| Closed | -$26K | – | 1379 |
|
|
2022
Q1 | $26K | Sell |
108
-66
| -38% | -$15.2K | ﹤0.01% | 1185 |
|
|
2021
Q4 | $39K | Buy |
174
+12
| +7% | +$2.53K | ﹤0.01% | 1083 |
|
|
2021
Q3 | $34K | Buy |
162
+37
| +30% | +$8.52K | ﹤0.01% | 1153 |
|
|
2021
Q2 | $30K | Sell |
125
-42,119
| -100% | -$10.4M | ﹤0.01% | 1093 |
|
|
2021
Q1 | $10.5M | Buy |
42,244
+17,253
| +69% | +$4.12M | 0.19% | 133 |
|
|
2020
Q4 | $5.75M | Buy |
24,991
+13,112
| +110% | +$3.02M | 0.14% | 164 |
|
|
2020
Q3 | $3.02M | Buy |
11,879
+11,502
| +3,051% | +$2.85M | 0.11% | 176 |
|
|
2020
Q2 | $88K | Buy |
+377
| New | +$86K | ﹤0.01% | 576 |
|
|
2018
Q4 | – | Sell |
-2,024
| Closed | -$419K | – | 615 |
|
|
2018
Q3 | $419K | Buy |
2,024
+150
| +8% | +$29.6K | 0.03% | 326 |
|
|
2018
Q2 | $345K | Buy |
1,874
+354
| +23% | +$62.6K | 0.02% | 265 |
|
|
2018
Q1 | $259K | Buy |
1,520
+120
| +9% | +$22K | 0.02% | 234 |
|
|
2017
Q4 | $243K | Buy |
1,400
+220
| +19% | +$38.9K | 0.03% | 213 |
|
|
2017
Q3 | $220K | Buy |
1,180
+140
| +13% | +$24.8K | 0.05% | 186 |
|
|
2017
Q2 | $179K | Buy |
1,040
+166
| +19% | +$27K | 0.06% | 230 |
|
|
2017
Q1 | $143K | Buy |
874
+76
| +10% | +$12.6K | 0.01% | 265 |
|
|
2016
Q4 | $116K | Buy |
798
+114
| +17% | +$17.2K | 0.01% | 315 |
|
|
2016
Q3 | $114K | Buy |
684
+342
| +100% | +$57.8K | 0.01% | 257 |
|
|
2016
Q2 | $52K | Buy |
342
+114
| +50% | +$17.7K | 0.01% | 337 |
|
|
2016
Q1 | $34 | Buy |
228
+76
| +50% | +$11.3K | ﹤0.01% | 354 |
|
|
2015
Q4 | $25K | Buy |
+152
| New | +$23.9K | ﹤0.01% | 376 |
|
Other funds holding AMGN
Penserra Capital Management's AMGN Position: Q2 2026 in Review
Penserra Capital Management reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $64.4K and leaving 597 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #692.
Penserra Capital Management first reported a position in AMGN in Q4 2015 and has held it in 35 quarters since. The position peaked at $133M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Penserra Capital Management held 597 shares of Amgen worth $215K as of Q2 2026.
- Penserra Capital Management sold 188 Amgen shares in Q2 2026, an estimated $64.4K.
- Amgen made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #692 holding.
- Penserra Capital Management first reported a position in Amgen in Q4 2015 and has held it in 35 quarters since.
- Penserra Capital Management's Amgen position peaked at $133M in Q2 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.